Atomistic AI for Materials Engineering
Entalpic replaces trial‑and‑error materials R&D with a closed‑loop AI platform combining simulation and lab validation. It helps industry discover better catalysts and materials faster, with fewer experiments and clearer scale‑up paths.
Interview with Alexandre Duval, Entalpic

Materials underpin every modern technology, yet R&D is still constrained by human bandwidth: too many possible formulations, too much scattered information, and too many objectives to optimize at once, with limited access to rapid experimentation. Entalpic built a materials discovery platform that integrates AI models, automated quantum simulation workflows, and experimental validation. CHEManager spoke with Alexandre Duval, CSO and co-founder, about turning AI insights into deployable materials.
CHEManager: What is Entalpic’s core idea in one sentence?
Alexandre Duval: We replace trial-and-error materials R&D with an AI closed-loop discovery engine that turns millions of candidates into a few lab-validated materials, ready for industrial deployment.
What makes R&D for materials discovery so slow in the chemical industry?
A. Duval: Materials R&D is slow because chemists rely on human intuition to find a new material within an infinite search space, using slow, expensive, and often hard to reproduce lab experiments to validate their hypotheses. On top of that, teams need to optimize for multiple desirable properties under many constraints, accounting for years of prior research, which makes progress hard to scale without better tools.
Many companies claim “AI for materials.” What is different about your approach, and what chemistries do you focus on?
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
most read

ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.

Q1 2025 Chemical Industry: Diverging Trends
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

20 Years of CHEManager International
Incredible but true: CHEManager International is celebrating its 20th anniversary!

Relocation of Chemicals Production Footprint in Full Swing
A new Horváth study based on interviews with CxOs of Europe’s top chemical corporations reveals: The majority of board members expects no or only weak growth for the current year.

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance
The ECA Foundation, one of the most important not-for-profit organizations for regulatory expertise in the pharmaceutical industry, aims to become the largest independent GMP/GDP organization in the world.






